Synthesis and biological evaluation of novel 2-pyridinyl-[1,2,3]triazoles as inhibitors of transforming growth factor β1 type 1 receptor

被引:88
作者
Kim, DK
Kim, J
Park, HJ
机构
[1] Ewha Womans Univ, Coll Pharm, Seoul 120750, South Korea
[2] Sungkyunkwan Univ, Coll Pharm, Suwon 440746, Kyungkido, South Korea
关键词
2-pyridinyl-[1,2,3]triazoles; inhibitors; TGF-beta; 1; type; receptor; ALK5;
D O I
10.1016/j.bmcl.2004.03.024
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of 2-pyridinyl-[1,2,3]triazoles have been synthesized and evaluated for their ALK5 inhibitory activity in the luciferase reporter assays. Compound 8d showed significant ALK5 inhibition (SBE-luciferase activity, 25%; p3TP-luciferase activity, 17%) at a concentration of 5 muM that is comparable to that of SB-431542 (SBE-luciferase activity, 21%; p3TP-luciferase activity, 12%), but weak p38alpha MAP kinase inhibition (13%) at a concentration of 10 muM that is much lower than that of SB-431542 (54%). (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2401 / 2405
页数:5
相关论文
共 19 条
[1]   TGF-β and fibrosis [J].
Branton, MH ;
Kopp, JB .
MICROBES AND INFECTION, 1999, 1 (15) :1349-1365
[2]  
Bridges A J, 1993, Bioorg Med Chem, V1, P403, DOI 10.1016/S0968-0896(00)82150-1
[3]   Identification of novel inhibitors of the transforming growth factor β1 (TGF-β1) type 1 receptor (ALK5) [J].
Callahan, JF ;
Burgess, JL ;
Fornwald, JA ;
Gaster, LM ;
Harling, JD ;
Harrington, FP ;
Heer, J ;
Kwon, C ;
Lehr, R ;
Mathur, A ;
Olson, BA ;
Weinstock, J ;
Laping, NJ .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (05) :999-1001
[4]   Direct binding of Smad3 and Smad4 to critical TGFβ-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene [J].
Dennler, S ;
Itoh, S ;
Vivien, D ;
ten Dijke, P ;
Huet, S ;
Gauthier, JM .
EMBO JOURNAL, 1998, 17 (11) :3091-3100
[5]   Conversion of SB 203580-insensitive MBP kinase family members to drug-sensitive forms by a single amino-acid substitution [J].
Eyers, PA ;
Craxton, M ;
Morrice, N ;
Cohen, P ;
Goedert, M .
CHEMISTRY & BIOLOGY, 1998, 5 (06) :321-328
[6]   Therapeutic approaches to organ fibrosis [J].
Franklin, TJ .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 1997, 29 (01) :79-89
[7]   Regulation of stress-induced cytokine production by pyridinylimidazoles; Inhibition of CSBP kinase [J].
Gallagher, TF ;
Seibel, GL ;
Kassis, S ;
Laydon, JT ;
Blumenthal, MJ ;
Lee, JC ;
Lee, D ;
Boehm, JC ;
FierThompson, SM ;
Abt, JW ;
Soreson, ME ;
Smietana, JM ;
Hall, RF ;
Garigipati, RS ;
Bender, PE ;
Erhard, KF ;
Krog, AJ ;
Hofmann, GA ;
Sheldrake, PL ;
McDonnell, PC ;
Kumar, S ;
Young, PR ;
Adams, JL .
BIOORGANIC & MEDICINAL CHEMISTRY, 1997, 5 (01) :49-64
[8]  
GASTER LM, 2002, Patent No. 0240476
[9]  
GIRI N, 2003, ANN REV PHARM TOXICO, V43, P73
[10]   The TGFβ receptor activation process:: An inhibitor- to substrate-binding switch [J].
Huse, M ;
Muir, TW ;
Xu, L ;
Chen, YG ;
Kuriyan, J ;
Massagué, J .
MOLECULAR CELL, 2001, 8 (03) :671-682